“The Role of Serum Level of Indoleamine 2,3–dioxygenase 1 (IDO1) in Patients with Prostate Cancer” (2021) Medico Legal Update, 21(2), pp. 1402–1407. doi:10.37506/mlu.v21i2.2888.